Navigation Links
MAP Pharmaceuticals Reports 2008 Fourth Quarter and Year End Financial Results
Date:3/2/2009

P Pharmaceuticals' first Phase 3 clinical trial of UDB, the company and AstraZeneca are conducting further analyses of the clinical data to determine appropriate next steps for the program. In addition, the company expects to announce clinical results from the efficacy portion of its first Phase 3 clinical trial for MAP0004 during the first half of 2009. At that time the company expects to provide updated financial guidance for 2009.

About MAP Pharmaceuticals

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for children and adults suffering from chronic conditions that are not adequately treated by currently available medicines. The company has two product candidates in Phase 3 clinical trials. Unit Dose Budesonide is being developed in collaboration with AstraZeneca for the potential treatment of asthma in children, and MAP0004 is being developed for the potential treatment of migraine. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk, by capitalizing on their known safety, efficacy and commercialization history.

Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' expected cash requirements during 2009 described above. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including, without limitation, risks and uncertainties relating to the following: the enrollment, conduct, completion and reporting of clinical
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
2. Endo Pharmaceuticals Announces Extension of its Tender Offer for Shares of Indevus Pharmaceuticals
3. Alexza Pharmaceuticals Promotes Peter D. Noymer, PhD to Vice President, Product R&D
4. Alseres Pharmaceuticals, Inc. Announces $200,000 Financing
5. Endo Pharmaceuticals Reports Fourth Quarter and Full-Year Financial Results
6. Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
7. Anadys Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
8. Arbor Pharmaceuticals Announces the Launch of XYLAREX(TM) - A New Nonantibiotic Product for the Dietary Management of Recurrent Ear Infections in Children
9. Endo Pharmaceuticals Appoints William Montague to Board of Directors
10. Access Pharmaceuticals Closes Acquisition of MacroChem Corp.
11. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... single day event in Japan will be held ... Tokyo. Clinical data scientists will meet and discuss various topics ... single day event in China will be held November ... scientists attending this event will discuss topics around CDISC ADaM ... collected in clinical studies and beyond. , India will ...
(Date:9/23/2014)... ZEPHYRHILLS, FL (PRWEB) September 23, 2014 ... opening of the newly renovated Women’s Health Center ... square feet of space, the specially designed center ... women in East Pasco County. The Women’s Health ... and pelvic floor health, labor and delivery through ...
(Date:9/23/2014)... of California, Davis, and Academia Sinica, the preeminent ... have entered into a collaborative agreement to develop ... couples cutting-edge research with opportunities to translate innovative ... , The agreement was signed Sept.12 in Taipei ... UC Davis and President Chi-Huey Wong of Academia ...
(Date:9/23/2014)... Dallas, TX (PRWEB) September 23, 2014 ... be taken before making a purchase. It’s difficult to ... and it’s easy for them to manipulate their customers ... mitigate this dilemma, but they tend to lack in ... Consumer Health Reports was founded to fix this ...
(Date:9/23/2014)... -- A test used to diagnose lung cancer may not ... are more common, a new analysis says. One ... of what,s known as functional imaging. For lung cancer, a ... to the study authors. Cancerous tumors generally look different ... lungs that don,t have cancer, according to background information in ...
Breaking Medicine News(10 mins):Health News:PhUSE Further Expands its Global Community Into the Asian Region 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Consumer Health Reports Debuts Revolutionary Review Website 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2
... his team has performed an Endoscopic surgery for Frontal Sinus ... 25 years old patient in Venkateswara Hospital in Chennai, Tamilnadu, ... inflammation of the meninges that covers the brain and spinal ... fluid is produced in the inner ventricles of the brain ...
... the approval of the Government is attracting brickbats and bouquets. ... the scheme which the ICICI-Lombard is // meant ... some experts who contend that it will do no good ... system in the state. ,Every year all ...
... A unique world class healthcare facility, supported by Welcare World ... region. // A full service ambulatory health care service comprising ... services had been recently inagurated in Knowledge Village. ... open from 8 am to 11 pm and fucntions 6 ...
... has announced that five new Vietnamese provinces are infected by ... spread of bird flu virus as already more than 21 ... flu virus. Though, Vietnamese scientists have revealed that they have ... help to understand the mechanism of virus transmission and the ...
... high fat diet has been found to suppress the ... that regulates insulin secretion (beta cells of the pancreas). ... ,This molecular mechanism between diabetes (Type ... the University of California. During early stages of the ...
... the Yale School of Medicine has revealed that diet ... Until recently it was believed that there was a ... carbonated soft drinks. In their study published in the ... the researchers report that the link is unfounded, and ...
Cached Medicine News:Health News:Health Insurance Scheme Generates Conflicting Opinions 2Health News:State Of The Art Healthcare Facility Opened In 'New Dubai' by Welcare 2Health News:Soft Drinks May Reduce Esophageal Cancer Risk 2
(Date:9/23/2014)... , Sept. 23, 2014 Report ... study showing you trends, R&D and predicted revenues ... kinase inhibitors? Now get the latest analysis for ... trends, results, opportunities and revenue forecasts. Visiongain,s ... using protein kinase inhibition and related technology. There ...
(Date:9/23/2014)... BURLINGTON, Mass. , Sept. 23, 2014 ... in pricing and reimbursement (P&R) decision criteria ... along with expert insights into each country, ... messaging across different markets.  Global market access ... very specific market access requirements and challenges—and ...
(Date:9/23/2014)... 2014 Research and Markets  has announced the ... report to their offering. Diabetes is a ... Over 382 million people are estimated to be currently suffering ... 592 million by 2035. With a very high prevalence, ... and India , an increasing proportion ...
Breaking Medicine Technology:Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 2Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 3Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 4Kinase Inhibitors for Treating Cancer: Industry Analysis, R&D Trends and World Market Forecasts 2014-2024 5Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 2Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 3Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach 4Glycated Haemoglobin (HbA1c) Testing Market 2Glycated Haemoglobin (HbA1c) Testing Market 3
... Va., July 8, 2011 The Amerigroup Foundation recently ... the Rx Partnership to benefit the Rockbridge Area Free ... organization that works to provide uninsured Virginians with access ... broker to access and distribute free bulk prescription medications ...
... /PRNewswire-Asia-FirstCall/ -- Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" ... of premium branded Traditional Chinese Medicine ("TCM") consumer ... attending and presenting at the upcoming 2011 Global ... at the Intercontinental Hotel (888 Howard Street) in ...
Cached Medicine Technology:Amerigroup Foundation Presents Grant to Rx Partnership 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 2Nutrastar to Present at the Upcoming 2011 Global Hunter Securities Conference 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: